Champions Oncology, Inc.

CSBRNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
5.65 USD
↘ 0.11 (1.91%)AT CLOSE (11:59 AM EDT)
5.65
↘ 0.01 (0.09%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
5.65
↘ 0.01 (0.09%)
🔴Market: CLOSED
Open?$5.67
High?$5.67
Low?$5.65
Prev. Close?$5.76
Volume?895
Avg. Volume?9.6K
VWAP?$5.67
Rel. Volume?0.09x
Bid / Ask
Bid?$4.82 × 100
Ask?$7.81 × 100
Spread?$2.99
Midpoint?$6.31
Valuation & Ratios
Market Cap?78.5M
Shares Out?13.9M
Float?5.1M
Float %?36.4%
P/E Ratio?N/A
P/B Ratio?18.32
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A

Champions Oncology, Inc. (CSBR) is currently trading at $5.65. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CSBR trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
306
Market Cap
78.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.championsoncology.com
Listed
1994-10-31
Address
855 N. WOLFE STREET
BALTIMORE, MD 21205
Phone: 410-369-0365
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
2
Momentum?
73
Short Sent.?
71
Piotroski F-Score?1/9Weak
Altman Z-Score?-0.28Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?1.68%Low
Short Interest?84.7K
Days to Cover?7.6
Free Float5.1M
Avg Daily Volume11.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.98Weak
Quick Ratio?0.98Weak
Cash Ratio?0.34Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
80/100
P/E?
N/A▾
P/B?
Peers
100
S&P
8
18.32HIGH▾
P/S?
Peers
100
S&P
81
1.35CHEAP▾
P/FCF?
Peers
100
S&P
53
20.6FAIR▾
EV/EBITDA?
S&P
97
-92.3CHEAP▾
EV/Sales?
Peers
100
S&P
88
1.23CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-53.3%WEAK▾
ROA?
S&P
3
-8.0%WEAK▾
Cash Flow & Enterprise
FCF?$3.8M
Enterprise Value?$71.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist